EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: A cohort study

Seung Shin Park iD, Chang Ho Ahn, Seunghoo Lee, Woochang Lee, Won Woong Kim, Yu-Mi Lee, Su Jin Kim, Tae-Yon Sung, Kyu Eun Lee, Jung Hee Kim iD, Seung Hun Lee iD, Jung-Min Koh

Journal of Internal Medicine · 2024

DOI: 10.1111/joim.13791 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Internal Medicine, 2024. Verfasst von Seung Shin Park und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Pheochromocytoma, Adrenal Gland Neoplasms, Paraganglioma, Biomarkers, Tumor. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korean Endocrine Society, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The prevalence of metastatic pheochromocytoma and paraganglioma (PPGL) is approximately 15%–20%. Although there are indicators to assess metastatic risks, none of them predict metastasis reliably. Therefore, we aimed to develop and validate a scoring system using clinical, genetic, and biochemical risk factors to preoperatively predict the metastatic risk of PPGL.

Methods

In the cross‐sectional cohort ( n = 180), clinical, genetic, and biochemical risk factors for metastasis were identified using multivariate logistic regression analysis, and a novel scoring system was developed. The scoring system was validated and compared with the age, size of tumor, extra‐adrenal location, and secretory type (ASES) score in the longitudinal cohort ( n = 114).

Results

In the cross‐sectional cohort, pseudohypoxia group‐related gene variants ( SDHB , SDHD , or VHL ), methoxytyramine >0.16 nmol/L, and tumor size >6.0 cm were independently associated with metastasis after multivariate logistic regression. Using them, the gene variant, methoxytyramine, and size of tumor (GMS) score were developed. In the longitudinal cohort, Harrell's concordance index of the GMS score (0.873, 95% confidence interval [CI]: 0.738–0.941) was higher than that of the ASES score (0.713, 95% CI: 0.567–0.814, p = 0.007). In the longitudinal cohort, a GMS score ≥2 was significantly associated with a higher risk of metastasis (hazard ratio = 25.07, 95% CI: 5.65–111.20). A GMS score ≥2 ( p < 0.001), but not ASES score ≥2 ( p = 0.090), was associated with shorter progression‐free survival.

Conclusion

The GMS scoring system, which integrates gene variant, methoxytyramine level, and tumor size, provides a valuable preoperative approach to assess metastatic risk in PPGL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaAdrenal Gland NeoplasmsParagangliomaBiomarkers, TumorHumansMaleFemaleMiddle AgedCross-Sectional StudiesAdultSuccinate DehydrogenaseRisk FactorsVon Hippel-Lindau Tumor Suppressor ProteinCohort StudiesMetanephrineLongitudinal StudiesNeoplasm MetastasisAgedTumor BurdenDopamine

Stichwörter der Autor:innen

gene variantmethoxytyramineparagangliomapheochromocytoma

Substanzen

Biomarkers, TumorSuccinate DehydrogenaseSDHB protein, human3-methoxytyramineVHL protein, humanVon Hippel-Lindau Tumor Suppressor ProteinSDHD protein, humanMetanephrineDopamine

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Lunit, Seoul, Republic of Korea.
  • Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Seung Shin Park, Jung Hee Kim, Seung Hun Lee

Förderung

  • Korean Endocrine Society
  • Korea Health Industry Development Institute

Zitieren

APA

Park, S. S., Ahn, C. H., Lee, S., Lee, W., Kim, W. W., Lee, Y. M., Kim, S. J., Sung, T. Y., Lee, K. E., Kim, J. H., Lee, S. H., & Koh, J. M. (2024). Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: A cohort study. Journal of Internal Medicine. https://doi.org/10.1111/joim.13791

Vancouver

Park SS, Ahn CH, Lee S, Lee W, Kim WW, Lee YM, et al. Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: A cohort study. Journal of Internal Medicine. 2024. doi:10.1111/joim.13791

BibTeX
@article{Park2024,
  author = {Park, Seung Shin and Ahn, Chang Ho and Lee, Seunghoo and Lee, Woochang and Kim, Won Woong and Lee, Yu-Mi and Kim, Su Jin and Sung, Tae-Yon and Lee, Kyu Eun and Kim, Jung Hee and Lee, Seung Hun and Koh, Jung-Min},
  title = {Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: A cohort study},
  journal = {Journal of Internal Medicine},
  year = {2024},
  doi = {10.1111/joim.13791}
}
Kostenlos starten →